Skip to main content

Table 2 Cardiovascular drugs used during the follow-up period *

From: Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

Drug class, n(%) Deterioration in glucose tolerance (n = 24) No deterioration in glucose tolerance (n = 56) P value
Diuretics 6 (25%) 15 (27%) 0.87
β-blockers 19 (79%) 50 (89%) 0.23
α1-blockers 5 (21%) 11 (20%) 0.91
Calcium channel blockers 10 (42%) 19 (34%) 0.51
Angiotensin receptor antagonists 2 (8%) 3 (5%) 0.61
Long-acting nitrates 9 (38%) 20 (36%) 0.88
  1. * Besides low-dose aspirin, angiotensin-converting enzyme inhibitors, statins and clopidogrel.